Q4 2025 from the pivotal INFRONT-3 Phase 3 clinical trial of latozinemab in FTD-GRN, a severe, rare form of dementia with no ...

Over 25 years of studying individuals aged 80 and older — dubbed “SuperAgers” — Northwestern University scientists have seen ...

Dementia affects memory, thinking and understanding abilities. Its impact can be reduced to a great extent by maintaining a ...